Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24,758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing dendritic cell-based approaches for cancer immunotherapy.
Datta J, Terhune JH, Lowenfeld L, Cintolo JA, Xu S, Roses RE, Czerniecki BJ. Datta J, et al. Among authors: xu s. Yale J Biol Med. 2014 Dec 12;87(4):491-518. eCollection 2014 Dec. Yale J Biol Med. 2014. PMID: 25506283 Free PMC article. Review.
Reengineering dendritic cell-based anti-cancer vaccines.
Koski GK, Cohen PA, Roses RE, Xu S, Czerniecki BJ. Koski GK, et al. Among authors: xu s. Immunol Rev. 2008 Apr;222:256-76. doi: 10.1111/j.1600-065X.2008.00617.x. Immunol Rev. 2008. PMID: 18364007 Review.
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.
Datta J, Berk E, Xu S, Fitzpatrick E, Rosemblit C, Lowenfeld L, Goodman N, Lewis DA, Zhang PJ, Fisher C, Roses RE, DeMichele A, Czerniecki BJ. Datta J, et al. Among authors: xu s. Breast Cancer Res. 2015 May 23;17(1):71. doi: 10.1186/s13058-015-0584-1. Breast Cancer Res. 2015. PMID: 25997452 Free PMC article.
Progressive loss of anti-HER2 CD4+ T-helper type 1 response in breast tumorigenesis and the potential for immune restoration.
Datta J, Rosemblit C, Berk E, Showalter L, Namjoshi P, Mick R, Lee KP, Brod AM, Yang RL, Kelz RR, Fitzpatrick E, Hoyt C, Feldman MD, Zhang PJ, Xu S, Koski GK, Czerniecki BJ. Datta J, et al. Among authors: xu s. Oncoimmunology. 2015 Apr 1;4(10):e1022301. doi: 10.1080/2162402X.2015.1022301. eCollection 2015 Oct. Oncoimmunology. 2015. PMID: 26451293 Free PMC article.
24,758 results
You have reached the last available page of results. Please see the User Guide for more information.